0000899243-23-008289.txt : 20230314
0000899243-23-008289.hdr.sgml : 20230314
20230314083011
ACCESSION NUMBER: 0000899243-23-008289
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sorensen Mel
CENTRAL INDEX KEY: 0001444783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 23729268
MAIL ADDRESS:
STREET 1: 7 RAPPS RUN DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 134
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: P.O. BOX 134
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-10
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001444783
Sorensen Mel
C/O GALERA THERAPEUTICS, INC.
P.O. BOX 134
MALVERN
PA
19355
1
1
0
0
President and CEO
Common Stock
2023-03-10
4
P
0
100000
1.6812
A
332044
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.635 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Chris Degnan, Attorney-in-Fact for J. Mel Sorensen
2023-03-14